Profiling of differentially expressed proteins in stage IV Colorectal cancers with good and poor outcomes

Journal of Proteomics

Volumn 75, Issue 10, 2012, Pages 2983-2997

  Kim, Hye Jung ^a,b   Kang, Un Beom ^a   Lee, Hanna ^b   Jung, Ji Han ^a,c   Lee, Seung Taek ^b   Yu, Myeong Hee ^a   Kim, Hoguen ^b   Lee, Cheolju ^a,d  

^a Korea Institute of Science and Technology   (South Korea)

^b Yonsei University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d University of Science and Technology (UST)   (South Korea)

Author keywords

CICAT; Colorectal cancer; DIGE; Molecular staging; Prognostic biomarker

Indexed keywords

ALPHA5 INTEGRIN; ANNEXIN; CALPONIN; CARCINOEMBRYONIC ANTIGEN; CAVEOLIN 1; COLLAGEN; DEFENSIN; DESMIN; EOSINOPHIL PEROXIDASE; FATTY ACID BINDING PROTEIN; FILAMIN A; FLUOROURACIL; FOCAL ADHESION KINASE 1; FOLINIC ACID; GLUTAMATE AMMONIA LIGASE; HISTONE H3; IMMUNOGLOBULIN J CHAIN; LAMININ; MUCIN 2; SMOOTHELIN; SYNAPTOPODIN; SYNTAXIN; TAPASIN; TROPOMYOSIN; VINCULIN;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; MALE; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADULT; AGED; CARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; METABOLOME; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROTEOME; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861344535     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.12.002     Document Type: Article

References (45)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. Kim H.J., Kang H.J., Lee H., Lee S.T., Yu M.H., Kim H., et al. Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 2009, 8:1368-1379.
3. Kim H.J., Yu M.H., Kim H., Byun J., Lee C. Noninvasive molecular biomarkers for the detection of colorectal cancer. BMB Rep 2008, 41:685-692.
4. Christofori G. New signals from the invasive front. Nature 2006, 441:444-450.
5. Walsh J.M., Terdiman J.P. Colorectal cancer screening: scientific review. JAMA 2003, 289:1288-1296.
6. Wood D.A. Clinical staging and end results classification: TNM system of clinical classification as applicable to carcinoma of the colon and rectum. Cancer 1971, 28:109-114.
7. Rudmik L.R., Magliocco A.M. Molecular mechanisms of hepatic metastasis in colorectal cancer. J Surg Oncol 2005, 92:347-359.
8. Dai C.Y., Haqq C.M., Puzas J.E. Molecular correlates of site-specific metastasis. Semin Radiat Oncol 2006, 16:102-110.
9. Agrawal D., Chen T., Irby R., Quackenbush J., Chambers A.F., Szabo M., et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002, 94:513-521.
10. Kim J., Mori T., Chen S.L., Amersi F.F., Martinez S.R., Kuo C., et al. Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann Surg 2006, 244:113-120.
11. Gronborg M., Kristiansen T.Z., Iwahori A., Chang R., Reddy R., Sato N., et al. Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach. Mol Cell Proteomics 2006, 5:157-171.
12. Lawlor K., Nazarian A., Lacomis L., Tempst P., Villanueva J. Pathway-based biomarker search by high-throughput proteomics profiling of secretomes. J Proteome Res 2009, 8:1489-1503.
13. Lilley K.S., Friedman D.B. All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 2004, 1:401-409.
14. Gygi S.P., Rist B., Gerber S.A., Turecek F., Gelb M.H., Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999, 17:994-999.
15. Cheadle C., Cho-Chung Y.S., Becker K.G., Vawter M.P. Application of z-score transformation to Affymetrix data. Appl Bioinformatics 2003, 2:209-217.
16. Kim H., Nam S.W., Rhee H., Shan Li L., Ju Kang H., Hye Koh K., et al. Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas. Oncogene 2004, 23:6218-6225.
17. Fu C., Hu J., Liu T., Ago T., Sadoshima J., Li H. Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J Proteome Res 2008, 7:3789-3802.
18. Thon J.N., Schubert P., Duguay M., Serrano K., Lin S., Kast J., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 2008, 48:425-435.
19. Crosnier C., Stamataki D., Lewis J. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet 2006, 7:349-359.
20. Vogelstein B., Kinzler K.W. Cancer genes and the pathways they control. Nat Med 2004, 10:789-799.
21. Jimenez C.R., Knol J.C., Meijer G.A., Fijneman R.J. Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers. J Proteomics 2010, 73:1873-1895.
22. Madoz-Gurpide J., Canamero M., Sanchez L., Solano J., Alfonso P., Casal J.I. A proteomics analysis of cell signaling alterations in colorectal cancer. Mol Cell Proteomics 2007, 6:2150-2164.
23. Watanabe T., Wu T.T., Catalano P.J., Ueki T., Satriano R., Haller D.G., et al. Molecular predictors of survival after adjuvant chemotherapy for colon cancer. N Engl J Med 2001, 344:1196-1206.
24. Maehara Y., Kakeji Y., Kabashima A., Emi Y., Watanabe A., Akazawa K., et al. Role of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinoma. J Clin Oncol 1999, 17:607-614.
25. Saito H., Tsujitani S., Oka S., Kondo A., Ikeguchi M., Maeta M., et al. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma. Anticancer Res 2000, 20:4489-4493.
26. Troppmair J., Bruder J.T., Munoz H., Lloyd P.A., Kyriakis J., Banerjee P., et al. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation. J Biol Chem 1994, 269:7030-7035.
27. deFazio A., Chiew Y.E., Sini R.L., Janes P.W., Sutherland R.L. Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. Int J Cancer 2000, 87:487-498.
28. Wang X., Wang Q., Hu W., Evers B.M. Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-kappaB-dependent pathway. Oncogene 2004, 23:1885-1895.
29. Friedl P., Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3:362-374.
30. Shatz M., Liscovitch M. Caveolin-1: a tumor-promoting role in human cancer. Int J Radiat Biol 2008, 84:177-189.
31. Karam J.A., Lotan Y., Roehrborn C.G., Ashfaq R., Karakiewicz P.I., Shariat S.F. Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence. Prostate 2007, 67:614-622.
32. Kawashiri S., Tanaka A., Noguchi N., Hase T., Nakaya H., Ohara T., et al. Significance of stromal desmoplasia and myofibroblast appearance at the invasive front in squamous cell carcinoma of the oral cavity. Head Neck 2009, 31:1346-1353.
33. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
34. De Wever O., Nguyen Q.D., Van Hoorde L., Bracke M., Bruyneel E., Gespach C., et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. FASEB J 2004, 18:1016-1018.
35. Tsujino T., Seshimo I., Yamamoto H., Ngan C.Y., Ezumi K., Takemasa I., et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res 2007, 13:2082-2090.
36. Du Z.M., Hu C.F., Shao Q., Huang M.Y., Kou C.W., Zhu X.F., et al. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 2009, 125:1832-1841.
37. Watanabe K., Nagai K., Kobayashi A., Sugito M., Saito N. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg 2009, 96:1058-1065.
38. Yanagisawa Y., Takeoka M., Ehara T., Itano N., Miyagawa S., Taniguchi S. Reduction of Calponin h1 expression in human colon cancer blood vessels. Eur J Surg Oncol 2008, 34:531-537.
39. Ma Y., Peng J., Liu W., Zhang P., Huang L., Gao B., et al. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer. Mol Cell Proteomics 2009, 8:1878-1890.
40. Pantano F., Baldi A., Santini D., Vincenzi B., Borzomati D., Vecchio F.M., et al. MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients. Cancer Biol Ther 2009, 8:996-999.
41. Zhao L., Wang H., Deng Y.J., Wang S., Liu C., Jin H., et al. Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod Pathol 2009, 22:786-796.
42. Esseghir S., Kennedy A., Seedhar P., Nerurkar A., Poulsom R., Reis-Filho J.S., et al. Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteins. Clin Cancer Res 2007, 13:3164-3173.
43. Yamamoto S., Tomita Y., Hoshida Y., Sakon M., Kameyama M., Imaoka S., et al. Expression of valosin-containing protein in colorectal carcinomas as a predictor for disease recurrence and prognosis. Clin Cancer Res 2004, 10:651-657.
44. Li L., Wu Y.P., Liu Y.Y., Yu X.R., Chen Z.R. A multivariate analysis of pathologic factors influencing prognosis of colorectal cancer in 1067 cases. Proc Chin Acad Med Sci Peking Union Med Coll 1989, 4:38-42.
45. Seo Y., Baba H., Fukuda T., Takashima M., Sugimachi K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000, 88:2239-2245.